Amedisys, Inc.

AMED

US0234361089

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
91.79 ^USD	+0.69%		+1.54%	-3.44%

Apr. 24	Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03	MT
Apr. 24	Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys

March 19, 2024 at 06:16 pm EDT

(Reuters) - Amedisys said on Tuesday Oregon's health authority has started a review of UnitedHealth Group's $3.3 billion acquisition of the home health and hospice caregiver.

UnitedHealth had announced the acquisition in June, after competing with Option Care Health.

The acquisition was meant to help expand UnitedHealth's presence in home healthcare, a business it bolstered through a $5.4 billion deal to buy Amedisys' rival, LHC Group, last year.

Oregon's notice said it expects to complete the review within 180 days within receipt of a transaction form, which the agency had confirmed in December, according to Amedisys.

(Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri)

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	UNITEDHEALTH GROUP INC.	495.4 USD	+0.30%	-1.15%	456B
	AMEDISYS, INC.	91.79 USD	+0.69%	+1.54%	3B

Latest news about Amedisys, Inc.

Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03	Apr. 24	MT
Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says	Mar. 25	MT
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says	Mar. 25	MT
RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating	Mar. 25	MT
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys	Mar. 19	RE
UnitedHealth Faces Antitrust Probe in US	Feb. 28	MT
Earnings Flash (AMED) AMEDISYS Reports Q4 EPS $0.94	Feb. 21	MT
Amedisys, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Amedisys, Inc. Offers Advanced Molecular Testing to its Care Centers in Collaboration with Patient Choice Laboratories	Feb. 08	CI
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.	23-10-25	CI
Amedisys Q3 Adjusted Earnings, Net Service Revenue Decline	23-10-25	MT
Earnings Flash (AMED) AMEDISYS Posts Q3 EPS $0.98	23-10-24	MT
Amedisys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating	23-09-14	MT
Amedisys, Inc. Announces Management Changes	23-08-30	CI
Deutsche Bank Adjusts Amedisys Price Target to $101 From $97, Maintains Buy Rating	23-07-31	MT
Option Care Health Q2 Earnings, Revenue Increase	23-07-27	MT
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.	23-07-27	CI
Earnings Flash (AMED) AMEDISYS Posts Q2 EPS $1.37	23-07-26	MT
Amedisys, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-26	CI
North American Morning Briefing : Focus Fixed on -2-	23-07-07	DJ
Jefferies Downgrades Amedisys to Hold From Buy, Adjusts Price Target to $101 From $98	23-07-06	MT
North American Morning Briefing : Claims Data, GDP -2-	23-06-29	DJ
North American Morning Briefing : Chip Stocks Take -2-	23-06-28	DJ

Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Sector

Healthcare Facilities & Services

Calendar

2024-07-30 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Amedisys, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

91.79 USD

Average target price

97.78 USD

Spread / Average Target

+6.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Home Healthcare Services

	1st Jan change	Capi.
AMEDISYS, INC.	-3.44%	3B
BRIGHTSPRING HEALTH SERVICES, INC.	0.00%	1.81B
ADDUS HOMECARE CORPORATION	+1.82%	1.53B
THE PENNANT GROUP, INC.	+49.28%	624M
ENHABIT, INC.	-3.09%	503M
DOCGO INC.	-35.42%	368M
SAINT-CARE HOLDING CORPORATION	-13.04%	136M
KATO (HONG KONG) HOLDINGS LIMITED	+1.92%	67.7M

Home Healthcare Services

Amedisys, Inc.

Equities

AMED

US0234361089

Healthcare Facilities & Services

Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys

Stocks mentioned in the article

Latest news about Amedisys, Inc.

Chart Amedisys, Inc.

Company Profile

Income Statement Evolution

Ratings for Amedisys, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Home Healthcare Services